QA: BIOXYTRAN INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2020_BIOXYTRAN_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001445815')"}

Graph

Absolute values for 0001445815, BIOXYTRAN INC

  xvar xval
0 AssetsCurrent 219,628
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 1,018,915
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 507,273
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 1,124,194
11 remainder_Revenues 0
12 remainder_NetIncome -227,009
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 219,628
1 Liabilities 1,018,915
2 Expenses 1,631,467
3 Revenues 0
4 StockholdersEquity -799,287
5 NetIncome -1,858,476
6 ComprehensiveNetIncome -1,858,476
7 BaseVar 1,548,510
8 EconomicCapitalRatio -5.22

Edgar->Model Mapping

Feature Distribution

Change over Time